Investment opportunity in therapeutic to prevent PTOA (post-traumatic osteoarthritis)

CartilaGen is a clinical stage drug development company focused on identifying and building a portfolio of therapeutic assets to prevent post-traumatic osteoarthritis (PTOA), the progressive destruction of cartilage foll...